{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:34:14Z","timestamp":1794501254476,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.eururo.2025.11.024","type":"journal-article","created":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T20:58:59Z","timestamp":1766005139000},"page":"246-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA)"],"prefix":"10.1016","volume":"89","author":[{"given":"Emanuele","family":"Messina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Borrelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Sciarra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Laschena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debora","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Shaholli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio M.","family":"Magliocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"La Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8466-918X","authenticated-orcid":false,"given":"Valeria","family":"Panebianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2025.11.024_b0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.eururo.2025.11.024_b0010","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S1470-2045(13)70442-X","article-title":"Economic burden of cancer across the European Union: a population-based cost analysis","volume":"14","author":"Luengo-Fernandez","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2025.11.024_b0015","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jamaoncol.2022.7826","article-title":"Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050","volume":"9","author":"Chen","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2025.11.024_b0020","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","article-title":"EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on prostate cancer\u20142024 update. Part I: screening, diagnosis, and local treatment with curative intent","volume":"86","author":"Cornford","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0025","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/jama.2023.26491","article-title":"Functional outcomes after localized prostate cancer treatment","volume":"331","author":"Al Hussein Al Awamlh","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2025.11.024_b0030","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.eururo.2021.06.026","article-title":"Effects of magnetic resonance imaging targeting on overdiagnosis and overtreatment of prostate cancer","volume":"80","author":"Vickers","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0035","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.eururo.2020.12.010","article-title":"Early detection of prostate cancer in 2020 and beyond: facts and recommendations for the European Union and the European Commission","volume":"79","author":"Van Poppel","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0040","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","article-title":"MRI-targeted or standard biopsy for prostate-cancer diagnosis","volume":"378","author":"Kasivisvanathan","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.11.024_b0045","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.eururo.2018.11.023","volume":"75","author":"van der Leest","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cct.2015.02.008","article-title":"PROMIS\u2014prostate MR imaging study: a paired validating cohort study evaluating the role of multi-parametric MRI in men with clinical suspicion of prostate cancer","volume":"42","author":"El-Shater Bosaily","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.eururo.2025.11.024_b0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","article-title":"Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study","volume":"20","author":"Rouvi\u00e8re","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2025.11.024_b0060","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.eururo.2019.06.023","article-title":"Prostate magnetic resonance imaging, with or without magnetic resonance imaging-targeted biopsy, and systematic biopsy for detecting prostate cancer: a Cochrane systematic review and meta-analysis","volume":"77","author":"Drost","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eururo.2024.09.035","article-title":"Evaluating biparametric versus multiparametric magnetic resonance imaging for diagnosing clinically significant prostate cancer: an international, paired, noninferiority, confirmatory observer study","volume":"87","author":"Twilt","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0070","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.1007\/s00330-023-09605-0","article-title":"Low cancer yield in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: is it time to reconsider scoring categorization?","volume":"33","author":"Messina","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2025.11.024_b0075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2214\/AJR.20.24268","article-title":"PI-RADS Committee position on MRI without contrast medium in biopsy-naive men with suspected prostate cancer: narrative review","volume":"216","author":"Schoots","year":"2021","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.eururo.2025.11.024_b0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-070280","article-title":"Comparing biparametric to multiparametric MRI in the diagnosis of clinically significant prostate cancer in biopsy-naive men (PRIME): a prospective, international, multicentre, non-inferiority within-patient, diagnostic yield trial protocol","volume":"13","author":"Asif","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.eururo.2025.11.024_b0085","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/andr.13041","article-title":"The future direction of imaging in prostate cancer: MRI with or without contrast injection","volume":"9","author":"Pecoraro","year":"2021","journal-title":"Andrology"},{"key":"10.1016\/j.eururo.2025.11.024_b0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059482","article-title":"Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trial","volume":"12","author":"Nam","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.eururo.2025.11.024_b0095","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S1470-2045(21)00348-X","article-title":"Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial","volume":"22","author":"Nordstr\u00f6m","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2025.11.024_b0100","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1001\/jama.2024.3841","article-title":"Prostate cancer screening with PSA, kallikrein panel, and MRI: the ProScreen randomized trial","volume":"331","author":"Auvinen","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2025.11.024_b0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s00330-023-10019-1","article-title":"Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial\u2014Prostate Cancer Secondary Screening in Sapienza (PROSA)","volume":"34","author":"Messina","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2025.11.024_b0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.eururo.2019.02.033","article-title":"Prostate imaging reporting and data system version 2.1: 2019 update of prostate imaging reporting and data system version 2","volume":"76","author":"Turkbey","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0115","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20210528","article-title":"MRI-directed biopsy for primary detection of prostate cancer in a population of 223 men: MRI in-bore vs MRI-transrectal ultrasound fusion-targeted techniques","volume":"95","author":"Del Monte","year":"2022","journal-title":"BJR"},{"key":"10.1016\/j.eururo.2025.11.024_b0120","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.0219","article-title":"Assessment of the diagnostic accuracy of biparametric magnetic resonance imaging for prostate cancer in biopsy-naive men: the Biparametric MRI for Detection of Prostate Cancer (BIDOC) study","volume":"1","author":"Boesen","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2025.11.024_b0125","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1007\/s00330-020-06929-z","article-title":"ESUR\/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists\u2019 training","volume":"30","author":"De Rooij","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2025.11.024_b0130","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jmri.27879","article-title":"Convolutional neural networks for automated classification of prostate multiparametric magnetic resonance imaging based on image quality","volume":"55","author":"Cipollari","year":"2022","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.eururo.2025.11.024_b0135","doi-asserted-by":"crossref","first-page":"7068","DOI":"10.1007\/s00330-024-10795-4","article-title":"PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI","volume":"34","author":"De Rooij","year":"2024","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2025.11.024_b0140","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1001\/jamaoncol.2020.7456","article-title":"Population-based prostate cancer screening with magnetic resonance imaging or ultrasonography: the IP1-PROSTAGRAM study","volume":"7","author":"Eldred-Evans","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2025.11.024_b0145","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa1201637","article-title":"Quality-of-life effects of prostate-specific antigen screening","volume":"367","author":"Heijnsdijk","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.11.024_b0150","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.euf.2024.02.006","article-title":"Opportunistic prostate cancer screening with biparametric magnetic resonance imaging (VISIONING)","volume":"10","author":"Wetterauer","year":"2024","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2025.11.024_b0155","article-title":"Prevalence of MRI lesions in men responding to a GP-led invitation for a prostate health check: a prospective cohort study","volume":"2","author":"Moore","year":"2023","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.eururo.2025.11.024_b0160","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","article-title":"Prostate cancer screening with PSA and MRI followed by targeted biopsy only","volume":"387","author":"Hugosson","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.11.024_b0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2025.05.038","article-title":"Magnetic resonance imaging\u2013based biopsy strategies in prostate cancer screening: a systematic review","volume":"88","author":"Schoots","year":"2025","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamaoncol.2024.0734","article-title":"Magnetic resonance imaging in prostate cancer screening: a systematic review and meta-analysis","volume":"10","author":"Fazekas","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2025.11.024_b0175","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1470-2045(10)70146-7","article-title":"Mortality results from the G\u00f6teborg randomised population-based prostate-cancer screening trial","volume":"11","author":"Hugosson","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2025.11.024_b0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s44250-025-00196-9","article-title":"The health technology assessment approach of the economic value of diagnostic tests: a literature review","volume":"4","author":"Bardey","year":"2025","journal-title":"Discov Health Syst"},{"key":"10.1016\/j.eururo.2025.11.024_b0185","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s10198-019-01096-5","article-title":"Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study","volume":"20","author":"Lorenzoni","year":"2019","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.eururo.2025.11.024_b0190","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1002\/cam4.3932","article-title":"Cost\u2010effectiveness of multiparametric magnetic resonance imaging and MRI\u2010guided biopsy in a population\u2010based prostate cancer screening setting using a micro\u2010simulation model","volume":"10","author":"Getaneh","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.eururo.2025.11.024_b0195","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1001\/jamaoncol.2022.5252","article-title":"Cost-effectiveness of prostate cancer screening using magnetic resonance imaging or standard biopsy based on the STHLM3-MRI study","volume":"9","author":"Hao","year":"2023","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.eururo.2025.11.024_b0200","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.44856","article-title":"Cost-effectiveness of annual prostate MRI and potential MRI-guided biopsy after prostate-specific antigen test results","volume":"6","author":"Yun","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.eururo.2025.11.024_b0205","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1056\/NEJMp1405158","article-title":"Updating cost-effectiveness\u2014the curious resilience of the $50,000-per-QALY threshold","volume":"371","author":"Neumann","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2025.11.024_b0210","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.eururo.2021.07.024","article-title":"Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations for 2021","volume":"80","author":"Van Poppel","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0215","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1080\/13696998.2019.1678171","article-title":"Total cost of care for castration-resistant prostate cancer in a commercially insured population and a Medicare supplemental insured population","volume":"23","author":"Wu","year":"2020","journal-title":"J Med Econ"},{"key":"10.1016\/j.eururo.2025.11.024_b0220","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.eururo.2018.07.038","article-title":"Health economic analysis of open and robot-assisted laparoscopic surgery for prostate cancer within the prospective multicentre LAPPRO trial","volume":"74","author":"Forsmark","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0225","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1007\/s00330-020-07545-7","article-title":"MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences","volume":"31","author":"Bura","year":"2021","journal-title":"Eur Radiol"},{"key":"10.1016\/j.eururo.2025.11.024_b0230","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1111\/j.1464-410X.2012.11469.x","article-title":"Age\u2010related changes in prostate zonal volumes as measured by high\u2010resolution magnetic resonance imaging (MRI): a cross\u2010sectional study in over 500 patients","volume":"110","author":"Turkbey","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2025.11.024_b0235","doi-asserted-by":"crossref","first-page":"70","DOI":"10.21037\/tau.2017.12.31","article-title":"MRI in early prostate cancer detection: how to manage indeterminate or equivocal PI-RADS 3 lesions?","volume":"7","author":"Schoots","year":"2018","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.eururo.2025.11.024_b0240","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.euf.2019.06.014","article-title":"Prostate Imaging Reporting and Data System 3 category cases at multiparametric magnetic resonance for prostate cancer: a systematic review and meta-analysis","volume":"6","author":"Maggi","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.eururo.2025.11.024_b0245","first-page":"11793","article-title":"A combined MRI-PSAD risk stratification system for prioritizing prostate biopsies","volume":"31","author":"Bar-Yaakov","year":"2024","journal-title":"Can J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382504847X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382504847X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:31:48Z","timestamp":1771615908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228382504847X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S030228382504847X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2025.11.024","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA)","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2025.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}